{"cursor":"5737","size":15,"audio":[],"currentlang":"en","article":"{{Drugbox\n\n\n| Verifiedfields = changed verifiedrevid = 477237058 type = mab mab_type = Fab\n| source = xi/o target = CD41 7E3\n\n\n| tradename = Reopro Drugs.com = pregnancy_category = C (US)\n| legal_status = routes_of_administration = IV\n\n\n| bioavailability = protein_bound = metabolism = elimination_half-life = \n| CAS_number_Ref = CAS_number = 143653-53-6 ATC_prefix = B01 ATC_suffix = AC13\n| ATC_supplemental = ChemSpiderID_Ref = ChemSpiderID = NA PubChem = DrugBank_Ref\n| = DrugBank = DB00054 UNII_Ref = UNII = X85G7936GV KEGG_Ref = KEGG = D02778\n| ChEMBL_Ref = ChEMBL = 1201584\n\n\n | C=2101 | H=3229 | N=551 | O=673 | S=15 molecular_weight = 47455.4 g/mol\n}} 'Abciximab' (previously known as 'c7E3 Fab'), a glycoprotein IIb/IIIa\nreceptor antagonist manufactured by Janssen Biologics BV and distributed by Eli\nLilly under the trade name 'ReoPro', is a platelet aggregation inhibitor mainly\nused during and after coronary artery procedures like angioplasty to prevent\nplatelets from sticking together and causing thrombus (blood clot) formation\nwithin the coronary artery. It is a glycoprotein IIb/IIIa inhibitor.\n\nWhile abciximab has a short plasma half-life, due to its strong affinity for its\nreceptor on the platelets, it may occupy some receptors for weeks. In practice,\nplatelet aggregation gradually returns to normal about 96 to 120 hours after\ndiscontinuation of the drug.(Tanguay, J.F., Eur Heart J 1999; 1 (suppl E): E27-\nE35 Abciximab is made from the Fab fragments of an immunoglobulin that targets\nthe glycoprotein IIb/IIIa receptor on the platelet membrane.\n","linknr":391,"url":"abciximab","recorded":1376424213,"links":["/w/index.php?title=Abciximab&action=edit","/w/index.php?title=Abciximab&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","http://en.wikipedia.org/wiki/Abciximab","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.visualEditor.viewPageTarget.noscript&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","#mw-navigation","#p-search","/wiki/Nomenclature_of_monoclonal_antibodies","/wiki/Monoclonal_antibody#Applications","/wiki/File:Engineered_monoclonal_antibodies.svg","/wiki/Fab_fragment","/wiki/Monoclonal_antibody#Production","/wiki/Chimeric_antibody","/wiki/Mouse","/wiki/Human","/wiki/Antigen","/wiki/CD41","/wiki/Trade_name","/wiki/American_Society_of_Health-System_Pharmacists","/wiki/Drugs.com","http://www.drugs.com/monograph/abciximab.html","/wiki/Pregnancy_category","/wiki/(US)","/wiki/Regulation_of_therapeutic_goods","/wiki/Route_of_administration","/wiki/Intravenous","/wiki/Biological_half-life","/wiki/CAS_registry_number","http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=143653-53-6&rn=1","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/Anatomical_Therapeutic_Chemical_Classification_System","/wiki/ATC_code_B01","http://www.whocc.no/atc_ddd_index/?code=B01AC13","/wiki/DrugBank","http://www.drugbank.ca/drugs/DB00054","/wiki/Unique_Ingredient_Identifier","http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=X85G7936GV","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/KEGG","http://www.kegg.jp/entry/D02778","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/ChEMBL","https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1201584","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","/wiki/Chemical_formula","/wiki/Carbon","/wiki/Hydrogen","/wiki/Nitrogen","/wiki/Oxygen","/wiki/Sulfur","/wiki/Molecular_mass","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png","/wiki/Wikipedia:WikiProject_Chemicals/Chembox_validation","//en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477237058&page2=Abciximab","/wiki/Glycoprotein_IIb/IIIa","/w/index.php?title=Janssen_Biologics_BV&action=edit&redlink=1","/wiki/Eli_Lilly_and_Company","/wiki/Platelet_aggregation_inhibitor","/wiki/Coronary_artery","/wiki/Angioplasty","/wiki/Platelet","/wiki/Blood_clot","/wiki/Glycoprotein_IIb/IIIa_inhibitor","#cite_note-1","/wiki/Platelet","/wiki/Fragment_antigen_binding","/wiki/Immunoglobulin","#cite_note-INN-2","#Indications_for_use","#Pharmacokinetics","#Side-effects","#References","#External_links","/w/index.php?title=Abciximab&action=edit&section=1","/w/index.php?title=Abciximab&veaction=edit&section=1","#cite_note-3","#cite_note-4","/w/index.php?title=Abciximab&action=edit&section=2","/w/index.php?title=Abciximab&veaction=edit&section=2","/wiki/Half-life","/w/index.php?title=Abciximab&action=edit&section=3","/w/index.php?title=Abciximab&veaction=edit&section=3","/wiki/Hemorrhage","/wiki/Thrombocytopenia","/wiki/Platelet","/wiki/Wikipedia:Citation_needed","/w/index.php?title=Abciximab&action=edit&section=4","/w/index.php?title=Abciximab&veaction=edit&section=4","#cite_ref-1","http://www.drugs.com/cdi/abciximab.html","http://web.archive.org/web/20100420014357/http://www.drugs.com/cdi/abciximab.html","#cite_ref-INN_2-0","http://whqlibdoc.who.int/inn/proposed_lists/prop_INN_list70.pdf","#cite_ref-3","/wiki/Digital_object_identifier","http://dx.doi.org/10.1056%2FNEJM199404073301402","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/8121459","#cite_ref-4","/wiki/Digital_object_identifier","http://dx.doi.org/10.1161%2F01.CIR.0000087601.45803.86","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/12939213","/wiki/Help:CS1_errors#displayauthors","/w/index.php?title=Abciximab&action=edit&section=5","/w/index.php?title=Abciximab&veaction=edit&section=5","http://www.reopro.com","/wiki/Template:Antithrombotics","/wiki/Template_talk:Antithrombotics","//en.wikipedia.org/w/index.php?title=Template:Antithrombotics&action=edit","/wiki/Antithrombotic","/wiki/Thrombolytic_drug","/wiki/Anticoagulant","/wiki/Antiplatelet_drug","/wiki/ATC_code_B01","/wiki/Antiplatelet_drug","/wiki/Glycoprotein_IIb/IIIa_inhibitors","/wiki/Eptifibatide","/wiki/Tirofiban","/wiki/P2Y12","/wiki/Adenosine_diphosphate_receptor_inhibitor","/wiki/Thienopyridine","/wiki/Clopidogrel","/wiki/Prasugrel","/wiki/Ticlopidine","/wiki/Nucleotide","/wiki/Nucleoside","/wiki/Cangrelor","/wiki/Elinogrel","/wiki/Ticagrelor","/wiki/Prostaglandin_analogue","/wiki/Prostacyclin","/wiki/Beraprost","/wiki/Iloprost","/wiki/Prostacyclin","/wiki/Treprostinil","/wiki/Mechanism_of_action_of_aspirin","/wiki/Aspirin","/wiki/Aloxiprin","/wiki/Carbasalate_calcium","/wiki/Indobufen","/wiki/Triflusal","/wiki/Thromboxane_inhibitors","/wiki/Thromboxane_synthase_inhibitors","/wiki/Dipyridamole","/wiki/Picotamide","/wiki/Thromboxane_receptor_antagonist","/wiki/Terutroban","/wiki/Phosphodiesterase_inhibitor","/wiki/Cilostazol","/wiki/Dipyridamole","/wiki/Triflusal","/wiki/Cloricromen","/wiki/Ditazole","/wiki/Anticoagulant","/wiki/Vitamin_K_antagonist","/wiki/Thrombin","/wiki/Factor_VII","/wiki/Factor_IX","/wiki/Factor_X","/wiki/Coumarin","/wiki/Acenocoumarol","/wiki/Coumatetralyl","/wiki/Dicoumarol","/wiki/Ethyl_biscoumacetate","/wiki/Phenprocoumon","/wiki/Warfarin","/wiki/1,3-Indandione","/wiki/Clorindione","/wiki/Diphenadione","/wiki/Phenindione","/wiki/Tioclomarol","/wiki/Factor_Xa","/wiki/Heparin","/wiki/Glycosaminoglycan","/wiki/Antithrombin","/wiki/Low_molecular_weight_heparin","/wiki/Bemiparin_sodium","/wiki/Certoparin_sodium","/wiki/Dalteparin_sodium","/wiki/Enoxaparin_sodium","/wiki/Nadroparin_calcium","/wiki/Parnaparin_sodium","/wiki/Reviparin_sodium","/wiki/Tinzaparin_sodium","/wiki/Oligosaccharide","/wiki/Fondaparinux","/wiki/Idraparinux","/wiki/Heparinoid","/wiki/Danaparoid","/wiki/Dermatan_sulfate","/wiki/Sulodexide","/wiki/Direct_Xa_inhibitor","/wiki/Apixaban","/wiki/Betrixaban","/wiki/Edoxaban","/wiki/Otamixaban","/wiki/Rivaroxaban","/wiki/Direct_thrombin_inhibitor","/wiki/Direct_thrombin_inhibitor#Bivalent","/wiki/Hirudin","/wiki/Bivalirudin","/wiki/Desirudin","/wiki/Lepirudin","/wiki/Direct_thrombin_inhibitor#Univalent","/wiki/Argatroban","/wiki/Dabigatran","/wiki/Melagatran","/wiki/Ximelagatran","/wiki/Antithrombin","/wiki/Defibrotide","/wiki/Protein_C","/wiki/Drotrecogin_alfa","/wiki/Ramatroban","/wiki/REG1","/wiki/Thrombolytic_drug","/wiki/Fibrinolytic","/wiki/Plasminogen_activator","/wiki/Recombinant_tissue_plasminogen_activators","/wiki/Tissue_plasminogen_activator","/wiki/Reteplase","/wiki/Tenecteplase","/wiki/Saruplase","/wiki/Urokinase","/wiki/Anistreplase","/wiki/Monteplase","/wiki/Streptokinase","/wiki/Serine_endopeptidase","/wiki/Ancrod","/wiki/Brinase","/wiki/Fibrinolysin","/wiki/Anticoagulant#Anticoagulants_outside_the_body","/wiki/Citrate","/wiki/Ethylenediaminetetraacetic_acid","/wiki/Oxalate","/wiki/List_of_World_Health_Organization_Essential_Medicines","/wiki/List_of_withdrawn_drugs","/wiki/Clinical_trial","/wiki/Clinical_trial#Phase_III","/wiki/Clinical_trial#Phase_II","/wiki/Template:Medicine_navs","/wiki/Myeloid","/wiki/Template:Myeloid_blood_cells_and_plasma","/wiki/Template:Myeloid_physiology","/wiki/Template:Coagulation","/wiki/Template:Hemeproteins","/wiki/Template:Myeloid_innate_immune_system","/wiki/Template:Granule_contents","/wiki/Template:Colony-stimulating_factors","/wiki/Template:Diseases_of_RBCs_and_megakaryocytes","/wiki/Template:Monocyte_and_granulocyte_disease","/wiki/Template:Myeloid_malignancy","/wiki/Template:Histiocytosis","/wiki/Template:Cardiovascular_system_symptoms_and_signs","/wiki/Template:Eponymous_medical_signs_for_hematology","/wiki/Template:Abnormal_clinical_and_laboratory_findings_for_blood","/wiki/ATC_code_B","/wiki/Template:Antithrombotics","/wiki/Template:Antihemorrhagics","/wiki/Template:B03,_B05,_B06","/wiki/Template:Myeloid_blood_tests","/wiki/Template:Transfusion_medicine","/wiki/Template:Monoclonals_for_bone,_musculoskeletal,_circulatory,_and_neurologic_systems","/wiki/Template_talk:Monoclonals_for_bone,_musculoskeletal,_circulatory,_and_neurologic_systems","//en.wikipedia.org/w/index.php?title=Template:Monoclonals_for_bone,_musculoskeletal,_circulatory,_and_neurologic_systems&action=edit","/wiki/Monoclonal","/wiki/Bone","/wiki/Denosumab","/wiki/Blosozumab","/wiki/Romosozumab","/wiki/Musculoskeletal","/wiki/Stamulumab","/wiki/Circulatory_system","/wiki/Alirocumab","/wiki/Enoticumab","/wiki/Evolocumab","/wiki/Icrucumab","/wiki/Inclacumab","/wiki/Nesvacumab","/wiki/Orticumab","/wiki/Ramucirumab","/wiki/Vesencumab","/wiki/Indium_(111In)_biciromab","/wiki/Indium_(111In)_imciromab","/wiki/Chimeric_antibody","/wiki/Volociximab","/wiki/Humanized_antibody","/wiki/Alacizumab_pegol","/wiki/Bevacizumab","/wiki/Ranibizumab","/wiki/Caplacizumab","/wiki/Demcizumab","/wiki/Etaracizumab","/wiki/Tadocizumab","/wiki/Neurologic","/wiki/Atinumab","/wiki/Fasinumab","/wiki/Fulranumab","/wiki/Gantenerumab","/wiki/Bapineuzumab","/wiki/Crenezumab","/wiki/Ozanezumab","/wiki/Ponezumab","/wiki/Solanezumab","/wiki/Tanezumab","/wiki/Angiogenesis_inhibitor","/wiki/Ranibizumab","/wiki/List_of_World_Health_Organization_Essential_Medicines","/wiki/List_of_withdrawn_drugs","/wiki/Clinical_trial","/wiki/Clinical_trial#Phase_III","/wiki/Clinical_trial#Phase_II","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=Abciximab&oldid=566867593","/wiki/Help:Categories","/wiki/Category:GpIIb/IIIa_inhibitors","/wiki/Category:Monoclonal_antibodies","/wiki/Category:Centocor","/wiki/Category:Pages_using_citations_with_old-style_implicit_et_al.","/wiki/Category:Chemical_compounds_which_do_not_have_a_ChemSpiderID","/wiki/Category:Articles_with_changed_EBI_identifier","/wiki/Category:Drugboxes_which_contain_changes_to_verified_fields","/wiki/Category:All_articles_with_unsourced_statements","/wiki/Category:Articles_with_unsourced_statements_from_March_2007","/w/index.php?title=Special:UserLogin&returnto=Abciximab&type=signup","/w/index.php?title=Special:UserLogin&returnto=Abciximab","/wiki/Abciximab","/wiki/Talk:Abciximab","#","/wiki/Abciximab","/w/index.php?title=Abciximab&action=edit","/w/index.php?title=Abciximab&veaction=edit","/w/index.php?title=Abciximab&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Abciximab","/wiki/Special:RecentChangesLinked/Abciximab","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Abciximab&oldid=566867593","/w/index.php?title=Abciximab&action=info","//www.wikidata.org/wiki/Q307088","/w/index.php?title=Special:Cite&page=Abciximab&id=566867593","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Abciximab","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Abciximab&oldid=566867593&writer=rl","/w/index.php?title=Abciximab&printable=yes","//ar.wikipedia.org/wiki/%D8%A3%D8%A8%D8%B3%D9%8A%D9%83%D8%B3%D9%8A%D9%85%D8%A7%D8%A8","//de.wikipedia.org/wiki/Abciximab","//es.wikipedia.org/wiki/Abciximab","//fr.wikipedia.org/wiki/Abciximab","//it.wikipedia.org/wiki/Abciximab","//pl.wikipedia.org/wiki/Abciksimab","//pt.wikipedia.org/wiki/Abciximab","#","//www.wikidata.org/wiki/Q307088#sitelinks-wikipedia","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/Abciximab","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":[],"pdf":["http://whqlibdoc.who.int/inn/proposed_lists/prop_INN_list70.pdf"],"categories":["GpIIb/IIIa inhibitors","Monoclonal antibodies","Centocor"],"headings":["Indications for use","Pharmacokinetics","Side-effects","References","External links"],"image":["//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[["(us"]],"members":[],"related":["CD41","(US)","Intravenous","Glycoprotein_IIb/IIIa","Janssen_Biologics_BV","Eli_Lilly_and_Company","Platelet_aggregation_inhibitor","Coronary_artery","Angioplasty","Platelet","Blood_clot","Glycoprotein_IIb/IIIa_inhibitor","Platelet","Fragment_antigen_binding","Immunoglobulin","Half-life","Hemorrhage","Thrombocytopenia","Platelet"]}